Verity Asset Management, Inc. Madrigal Pharmaceuticals, Inc. Transaction History
Verity Asset Management, Inc.
- $209 Billion
- Q2 2025
A detailed history of Verity Asset Management, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Verity Asset Management, Inc. holds 1,717 shares of MDGL stock, worth $760,648. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,717
Previous 1,560
10.06%
Holding current value
$760,648
Previous $517 Million
0.56%
% of portfolio
0.25%
Previous 0.21%
Shares
19 transactions
Others Institutions Holding MDGL
# of Institutions
356Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$971 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$926 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$883 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$875 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$832 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.58B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...